OX40 agonists for cancer treatment: a patent review.
Cebada J, Perez-Santos M, Bandala C, Lara-Padilla E, Herrera-Camacho I, Rosas-Murrieta NH, Millán-Pérez Peña L, Monjaraz E, Flores A, Anaya-Ruiz M.
Cebada J, et al.
Expert Opin Ther Pat. 2021 Jan;31(1):81-90. doi: 10.1080/13543776.2021.1825688. Epub 2020 Oct 6.
Expert Opin Ther Pat. 2021.
PMID: 32945223
Review.